Chicago, IL, June 30, 2020 --(PR.com
)-- Out of hundreds of start-ups that applied, Script Health was selected to participate in the Emerge Program led by SoftBank in partnership with WeWork Labs. SoftBank Investment Advisers worked closely with start-ups to connect underrepresented founders with tools, networks, and resources to scale in tech and entrepreneurship.
The Emerge Program was a customized 8-week program held from April to June led by SoftBank’s Investment Advisors. The start-up incubator was designed to provide exclusive access to SoftBank professionals and portfolio companies, educational sessions, and connections across a global network.
Their opportunities included building relationships with key SoftBank professionals and portfolio companies, attending educational programs, accessing industry experts’ advice, and building influential international networks. The program wrapped up with a Showcase of each start-up’s refined business pitches in front of SoftBank Investment Advisers, WeWork Labs, and industry investment professionals. On June 18th, 2020, SoftBank announced its $2 Million Investment in the Emerge program’s first cohort of start-ups.
Innovation in the world is limited without the full participation of entrepreneurs from every background. SoftBank is a leader in the initiative to scale companies founded by diverse problem-solvers to maximize advancement.
About Script Health: Script Health is a public benefit company that built Naloxone Exchange - an online platform that offers information, training, and Naloxone kits to decrease opioid-related deaths. Founded by a pharmacist, our mission is to provide easy access to essential and life-saving treatments. Script Health has been supported by institutions including the Clinton Global Initiative, Stanford Medicine, MIT, and the University of Chicago.